Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Why MannKind's Afrezza Will Succeed Where Pfizer Failed

More strangeousity. Great article, can't take issue with most of what he writes, did his homework, but where in the world does the stuff about approval before the end of this year come from? It's like looking at a wonderfully constructed home, and seeing an outhouse right outside the back door!

Share
New Message
Please login to post a reply